Examkin

Question

Difficulty: Very hardPulmonary and Critical Care

A 3232-year-old woman is evaluated in the outpatient clinic for progressive exertional dyspnea and fatigue over the past 88 months. She has no prior medical conditions and does not use tobacco. Vital signs are within normal limits, though pulse oximetry shows 94%94\% on ambient air. Physical examination is notable for a prominent right ventricular heave, a loud pulmonic component of the second heart sound (P2P_2), and trace lower extremity pitting edema. The lungs are clear to auscultation. A chest radiograph reveals enlarged central pulmonary arteries with rapid tapering of the peripheral vessels. Electrocardiography shows right axis deviation.

Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for evaluating and managing this patient's suspected condition, from first to last.

  1. 1Perform transthoracic echocardiography
  2. 2Obtain a radionuclide ventilation/perfusion (V/Q) scan
  3. 3Perform right heart catheterization
  4. 4Administer inhaled nitric oxide during hemodynamic monitoring
  5. 5Initiate targeted pulmonary vasodilator therapy

Answer

The correct sequence is: Transthoracic echocardiography, followed by a V/Q scan, then right heart catheterization, followed by vasoreactivity testing with inhaled nitric oxide, and finally the initiation of targeted pulmonary vasodilator therapy.
The standard diagnostic algorithm for suspected pulmonary hypertension begins with a transthoracic echocardiogram to estimate pulmonary pressures and evaluate for left-sided heart failure. If echocardiography suggests pulmonary hypertension, the next essential step is a V/Q scan to evaluate for chronic thromboembolic pulmonary hypertension (CTEPH), as CTEPH is potentially curable with surgical pulmonary thromboendarterectomy. Once CTEPH and other secondary causes (like interstitial lung disease) are ruled out, a right heart catheterization is required to definitively confirm pulmonary arterial hypertension. During the catheterization, vasoreactivity testing (e.g., with inhaled nitric oxide) must be performed. Finally, the specific results of the invasive hemodynamic and vasoreactivity testing guide the initiation of targeted medical therapy.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient presents with classic signs of isolated right heart strain and pulmonary hypertension (dyspnea, clear lungs, right ventricular heave, loud P2).
Recognizing pulmonary hypertension is required to enter the correct diagnostic algorithm.
2
Determine the initial non-invasive screening test.
Transthoracic echocardiography is ordered first.
Echocardiography estimates pulmonary artery systolic pressure and evaluates for left heart disease, which is the most common overall cause of pulmonary hypertension.
3
Select the appropriate imaging to rule out thromboembolic disease.
A ventilation/perfusion (V/Q) scan is performed next.
A V/Q scan is more sensitive than CT pulmonary angiography for chronic thromboembolic pulmonary hypertension (CTEPH) and must be done prior to invasive hemodynamics.
4
Confirm the diagnosis invasively.
Right heart catheterization is performed.
Direct measurement of mean pulmonary arterial pressure (mPAP) and pulmonary capillary wedge pressure (PCWP) is required to formally diagnose Group 1 Pulmonary Arterial Hypertension (PAH).
5
Test for vasoreactivity and initiate appropriate treatment.
Inhaled nitric oxide is administered during catheterization, followed by starting appropriate vasodilator therapy.
Vasoreactivity testing determines if the patient will respond to calcium channel blockers; otherwise, specific advanced PAH therapies are selected based on the definitive hemodynamic profile.

Key Concept

The precise sequential diagnostic algorithm for evaluating suspected pulmonary hypertension.
Rate this question

Topics

Pulmonary and Critical Care

More questions from this topic